Jupiter Neurosciences CAO granted 341,843 stock options

JUPITER NEUROSCIENCES, INC. granted Chief Administrative Officer Alexander Gustaf Erik Rosen a stock option award covering 341,843 shares of common stock.

Rhea-AI Filing Summary

JUPITER NEUROSCIENCES, INC. granted Chief Administrative Officer Alexander Gustaf Erik Rosen a stock option award covering 341,843 shares of common stock. The options have an exercise price of $0.2783 per share and expire on June 2, 2036.

The grant was made as a discretionary bonus for services rendered during fiscal 2025 under the company’s 2025 Equity Incentive Plan. The options vest over three years starting September 2, 2026, in equal quarterly installments, subject to Rosen’s continued employment through each vesting date.

Insider Trade Summary

Grant/Award: 341,843 shares

Grant/Award 1 txn

Insider Rosen Alexander Gustaf Erik

Role Chief Administrative Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	341,843	$0.00	$0.00

Holdings After Transaction: Stock Option — 341,843 contracts (Direct)

Footnotes (1)

1. F1. 341,843 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date.

Key Figures

Option grant size: 341,843 options Exercise price: $0.2783 per share Underlying shares: 341,843 shares +3 more

6 metrics

Option grant size 341,843 options Granted to CAO as discretionary bonus for fiscal 2025

Exercise price $0.2783 per share Stock option strike price

Underlying shares 341,843 shares Common stock underlying the options

Expiration date June 2, 2036 Option term end date

Post‑grant option holdings 341,843 options Total stock options following transaction

Vesting commencement September 2, 2026 Start of three-year quarterly vesting schedule

Key Terms

2025 Equity Incentive Plan, discretionary bonus, vesting, Stock Option

4 terms

2025 Equity Incentive Plan financial

"341,843 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus"

discretionary bonus financial

"as a discretionary bonus for services rendered during fiscal 2025"

vesting financial

"The options vest over three years commencing from September 2, 2026 in equal quarterly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Stock Option financial

"security_title: Stock Option"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did JUNS executive Alexander Rosen receive in this Form 4 filing?

Alexander Rosen received a stock option grant for 341,843 shares of JUPITER NEUROSCIENCES common stock. The award was granted as a discretionary bonus for services rendered during fiscal 2025 under the company’s 2025 Equity Incentive Plan.

What is the exercise price of the JUNS stock options granted to Alexander Rosen?

The stock options granted to Alexander Rosen carry an exercise price of $0.2783 per share. This means he can purchase common stock at $0.2783 once the options vest and are exercised, regardless of the market price at that time.

How many JUNS shares are covered by Alexander Rosen’s new stock option grant?

The stock option grant covers 341,843 underlying shares of JUPITER NEUROSCIENCES common stock. Following this award, Rosen holds stock options for 341,843 shares directly, according to the reported post-transaction holdings in the Form 4.

How do Alexander Rosen’s JUNS stock options vest over time?

The options vest over three years starting on September 2, 2026, in equal quarterly installments. Each vesting date requires Alexander Rosen to remain employed with JUPITER NEUROSCIENCES through that date for the corresponding portion of the grant to vest.

When do Alexander Rosen’s JUNS stock options expire if unexercised?

The stock options granted to Alexander Rosen expire on June 2, 2036, if they are not exercised before that date. After expiration, any unexercised portion of the 341,843-share option grant will no longer be exercisable.

Under which plan were the JUNS stock options to Alexander Rosen granted?

The 341,843 stock options were granted under JUPITER NEUROSCIENCES’ 2025 Equity Incentive Plan. The filing notes that they were issued as a discretionary bonus for services rendered during fiscal 2025, highlighting their compensation-related nature.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 08:46 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rosen Alexander Gustaf Erik

(Last) (First) (Middle)

C/O JUPITER NEUROSCIENCES, INC.

1001 NORTH US HYWAY 1, SUITE 504

(Street)

JUPITER FLORIDA 33477

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JUPITER NEUROSCIENCES, INC. [ JUNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Administrative Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.2783	06/02/2026		A		341,843		(1)	06/02/2036	Common Stock	341,843	$0	341,843	D

Explanation of Responses:

1. 341,843 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date.

	/s/ Alexander Rosen	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)